Results 261 to 270 of about 770,597 (361)

Lifileucel tumor‐infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors

open access: yes
Cancer Communications, EarlyView.
Harriet Kluger   +16 more
wiley   +1 more source

Identification of the Novel Synthetic Opioid N‐Pyrrolidino Isotonitazene at an Australian Drug Checking Service

open access: yesDrug Testing and Analysis, EarlyView.
Close collaboration between an Australian drug checking service and an affiliated university laboratory identifies and characterises the novel synthetic opioid N‐pyrrolidino isotonitazene in an expected oxycodone sample presented by a member of the public.
Blake Curtis   +3 more
wiley   +1 more source

Implementation of echography in hospital emergency services

open access: gold, 2018
Adriana Gil   +3 more
openalex   +1 more source

Avoid Falsely Accusing Female Athletes Who Use Levonorgestrel of Doping

open access: yesDrug Testing and Analysis, EarlyView.
Levonorgestrel, a hormonal contraceptive, metabolises to 18‐methyl‐19‐noretiocholanolone which is also the main metabolite of the prohibited substance 18‐methyl‐19‐nortestosterone. Analysing for levonorgestrel and/or tetrahydronorgestrel is essential to avoid misinterpreting 18‐methyl‐19‐noretiocholanolone findings.
Alexander Andersson   +3 more
wiley   +1 more source

Lineage labeling with zebrafish hand2 Cre and CreERT2 recombinase CRISPR knock‐ins

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background The ability to generate endogenous Cre recombinase drivers using CRISPR‐Cas9 knock‐in technology allows lineage tracing, cell type‐specific gene studies, and in vivo validation of inferred developmental trajectories from phenotypic and gene expression analyses. This report describes endogenous zebrafish hand2 Cre and CreERT2 drivers
Zhitao Ming   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy